Zobrazeno 1 - 5
of 5
pro vyhledávání: '"MESH : Graft vs Leukemia Effect"'
Autor:
Emily Manktelow, Nathan J Robertson, Fazila Hashim, Julian Dyson, François A. Lemonnier, Diane Scott, Jian-Guo Chai, Maggie Millrain, Elizabeth Simpson
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2007, 178 (6), pp.3558-65. ⟨10.4049/jimmunol.178.6.3558⟩
Journal of Immunology, 2007, 178 (6), pp.3558-65. ⟨10.4049/jimmunol.178.6.3558⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2007, 178 (6), pp.3558-65. ⟨10.4049/jimmunol.178.6.3558⟩
Journal of Immunology, 2007, 178 (6), pp.3558-65. ⟨10.4049/jimmunol.178.6.3558⟩
MHC-matched hemopoietic stem cell transplantation is commonly used for the treatment of some forms of leukemia. Conditioning regimens before transplant act to reduce the burden of leukemic cells and the graft-vs-leukemia (GvL) effect can eliminate re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3622dc5793e525ea0a239640c4a7d74f
https://doi.org/10.4049/jimmunol.178.6.3558
https://doi.org/10.4049/jimmunol.178.6.3558
Autor:
Pierre Tiberghien, C. Faucher, Agnes Buzyn, M. Robin, Bruno Lioure, Etienne Daguindau, Eric Deconinck, M Kuentz
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2010, 45 (1), pp.177-80. ⟨10.1038/bmt.2009.96⟩
Bone Marrow Transplantation, Nature Publishing Group, 2010, 45 (1), pp.177-80. 〈10.1038/bmt.2009.96〉
Bone Marrow Transplantation, Nature Publishing Group, 2010, 45 (1), pp.177-80. ⟨10.1038/bmt.2009.96⟩
Bone Marrow Transplantation, Nature Publishing Group, 2010, 45 (1), pp.177-80. 〈10.1038/bmt.2009.96〉
International audience; Remissions of haematological malignancies have been reported after allo-SCT, despite donor cell rejection, suggesting that sustained allogeneic engraftment is not mandatory to obtain a lasting anti-tumour effect. To evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944476790a2726a202ce10bf58b43003
https://pubmed.ncbi.nlm.nih.gov/19430502
https://pubmed.ncbi.nlm.nih.gov/19430502
Autor:
David Laurin, Martine Pernollet, Agnès Moine, Jean-Claude Bensa, Joel Plumas, Jean-Yves Cahn, Frédéric Garban, Dalil Hannani
Publikováno v:
Transfusion
Transfusion, Wiley, 2010, 50 (2), pp.418-28. ⟨10.1111/j.1537-2995.2009.02440.x⟩
Transfusion, Wiley, 2010, 50 (2), pp.418-28. ⟨10.1111/j.1537-2995.2009.02440.x⟩
International audience; BACKGROUND: After HLA-identical hematopoietic stem cell transplantation, minor histocompatibility (mH) antigen alloreactivity plays a dominant role in the development of graft-versus-host disease (GVHD) and graft versus leukem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::938696e1ff06f758399b553c14e4858f
https://pubmed.ncbi.nlm.nih.gov/19843288
https://pubmed.ncbi.nlm.nih.gov/19843288
Autor:
Céline Cognet, Rita Maccario, Maria Ester Bernardo, Daniela Pende, Michela Falco, Maria Cristina Mingari, Franco Locatelli, Miryam Martinetti, Elisa Romeo, Stefania Martini, Lorenzo Moretta, Stefania Marcenaro, Daniela Montagna, Eric Vivier, Alessandro Moretta
Publikováno v:
Blood
Blood, American Society of Hematology, 2009, 113 (13), pp.3119-29. ⟨10.1182/blood-2008-06-164103⟩
Blood, 2009, 113 (13), pp.3119-29. ⟨10.1182/blood-2008-06-164103⟩
Blood, American Society of Hematology, 2009, 113 (13), pp.3119-29. ⟨10.1182/blood-2008-06-164103⟩
Blood, 2009, 113 (13), pp.3119-29. ⟨10.1182/blood-2008-06-164103⟩
We analyzed 21 children with leukemia receiving haploidentical hematopoietic stem cell transplantation (haplo-HSCT) from killer immunoglobulin (Ig)–like receptors (KIR) ligand-mismatched donors. We showed that, in most transplantation patients, var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4d06b713c60d8a8eef3f559dff2445
https://pubmed.ncbi.nlm.nih.gov/18945967
https://pubmed.ncbi.nlm.nih.gov/18945967
Autor:
Patrice Chevalier, Reza Tabrizi, Hervé Tilly, Bruno Lioure, Eric Deconinck, Gérard Socié, Jill-Patrice Cassuto, Lionel Ades, Didier Blaise, Mauricette Michallet, Mathieu Kuentz, Michel Attal, Pierre Bordigoni, Thierry Facon, Frédéric Garban, Jean-Paul Vernant, Stéphane Vigouroux, Noel Milpied, Marc Bernard, Norbert Ifrah, Jean-Henri Bourhis, Marc Renaud, Raphaël Porcher
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2007, 92 (5), pp.627-34
Haematologica, 2007, 92 (5), pp.627-34
HAL
Haematologica, Ferrata Storti Foundation, 2007, 92 (5), pp.627-34
Haematologica, 2007, 92 (5), pp.627-34
HAL
International audience; BACKGROUND AND OBJECTIVES: High-dose chemotherapy with allogeneic stem cell transplantation (SCT) has proven to be a successful treatment for low-grade lymphoma (LGL), but is associated with considerable transplant-related mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f71a790778690350e9b7db0e36e46f8
https://www.hal.inserm.fr/inserm-00507510/file/627.pdf
https://www.hal.inserm.fr/inserm-00507510/file/627.pdf
